Submissions were accepted until 19 November 2024
The EMIM 2025 Committee calls for original, unpublished work to be presented as oral or poster presentation. All presenters need to be registered and present in Bilbao.
Currently all submissions are closed – sorry.
Check back for potential late-breaking options!
Submitted an Abstract already – what’s next?
- The extensive reviewing process ends on 3 December.
- After that the programme building starts.
- Notifications on acceptance/rejection and type of presentation (poster/talk) will be sent on 3 January (at latest).
- You can view your abstract in the submission system anytime – but edits are not allowed.
- Just contact the us via office@e-smi.eu in case of any questions.
That’s new & important to know!
To give all your work the attention it deserves, the following rules have been implemented:
- The number of submissions as presenting author is limited to one (no limit on co-authorship).
- The overall number of submissions is limited to the top scored 750.
As a result, the chance of acceptance during the first deadline (19 Nov.) is likely to be higher and it is uncertain whether there will be a call for late-breaking submissions at all and if so, the competition is likely to be tough.
++ Make sure to provide data/figures to support your results & conclusion. ++
Proceed to submission rules here.
Abstract Categories
Abstract categories per main (IN BOLD CAPITALS) category
Note that for the following themes, the main category = abstract category: 7 – Musculoskeletal, 8 – Gastrointestinal, 11 – Metabolism, 12 – Advanced In Vitro Models
- PHYSICS, ENGINEERING & TECHNOLOGIES
- Ultrasound & Optoacoustic Technologies
- Multiscale Optical Technologies
- Magnetic Resonance Technologies (incl. Hyperpolarized MRI)
- X-Ray Technologies
- PET/SPECT/Hybrid Technologies
- Spatially Resolved Multi-Omics
- PROBE CHEMISTRY & REPORTER GENES
- MRI, MPI & Multimodal | Probes/Reporter Genes
- Optical, Optoacoustic, Ultrasound | Probes/Reporter Genes
- Diagnostic PET/SPECT, Radionuclide, X-Ray, CT | Probes/Reporter Genes
- Theranostic Agents | Probes/Reporter Genes
- RECONSTRUCTION, PROCESSING & ANALYSIS
- Quantification & Image Analysis
- Image Processing, AI, Reconstruction & Acquisition
- IMAGE-GUIDED THERAPY
- Image-Guided Drug Delivery
- Application of Theranostics
- Interventional & Surgical Imaging
- CARDIOVASCULAR & RESPIRATORY IMAGING
- Cardiac Imaging
- Vascular Imaging
- Pulmonary Imaging
- CNS & PERIPHERAL NERVES
- Brain (Micro-) Structure, Anatomy & Receptors
- Brain Metabolism, Function & Perfusion
- Neuroimaging Tools in Disease Models
- MUSCULOSKELETAL
- GASTROINTESTINAL
- ONCOLOGY
- Cancer Biology & Tumour Microenvironment
- Cancer Diagnosis
- Cancer Therapy (incl. Immunotherapy)
- IMMUNOLOGY, INFLAMMATION & INFECTION
- Imaging the Immune system
- Imaging of Infection
- METABOLISM
- ADVANCED IN VITRO MODELS
Timeline
- 24 Sep. 2024 | Opening of Abstract Submission
- 19 Nov. 2024 | Abstract Deadline
- 3 Jan. 2025 | Notification to Presenters
- 16 Jan. 2024 | Early Bird Registration Deadline